RCAG
XLRN

Rehmann Capital Advisory Group’s Acceleron Pharma Inc. XLRN Stock Holding History

Rehmann Capital Advisory Group’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-14
Closed -$679 – 2210
2018
Q2 		$679 Buy
+14
New +$679 ﹤0.01% 2031